par Van Den Neste, Eric;Martiat, Philippe
;Mineur, Philippe;Delannoy, André;Doyen, C;Zenebergh, A;Michaux, Jean Louis;Ferrant, Augustin
Référence Annals of hematology, 76, 1, page (19-23)
Publication Publié, 1998-01

Référence Annals of hematology, 76, 1, page (19-23)
Publication Publié, 1998-01
Article révisé par les pairs
Titre: |
|
Auteur: | Van Den Neste, Eric; Martiat, Philippe; Mineur, Philippe; Delannoy, André; Doyen, C; Zenebergh, A; Michaux, Jean Louis; Ferrant, Augustin |
Informations sur la publication: | Annals of hematology, 76, 1, page (19-23) |
Statut de publication: | Publié, 1998-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adolescent |
Adult | |
Aged | |
Antineoplastic Agents -- therapeutic use | |
Cladribine -- administration & dosage | |
Cladribine -- adverse effects | |
Cladribine -- therapeutic use | |
Daunorubicin -- administration & dosage | |
Daunorubicin -- adverse effects | |
Female | |
Humans | |
Leukemia, Myeloid, Acute -- drug therapy | |
Leukemia, Myeloid, Acute -- mortality | |
Male | |
Middle Aged | |
Recurrence | |
Survival Rate | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase II | |
Journal Article | |
Randomized Controlled Trial | |
Langue: | Anglais |
Identificateurs: | urn:issn:0939-5555 |
info:pmid/9486920 |